High-Risk Device Scrutiny On Agenda Of Next Trilogue On EU Medtech Reforms
This article was originally published in SRA
Executive Summary
The scrutiny of high-risk devices, one of the areas within the proposed EU medtech regulations on which the authorities have found most difficulty to agree, will be up for debate on Feb. 4.